AI’s influence today is outpacing industry readiness
Responsible use of artificial intelligence (AI) plays a pivotal role in this transformation. Healthcare organizations must be confident that the underlying clinical logic of digital health tools is not only trustworthy but also supported by a reliable medication intelligence layer. Some recent reports suggest that AI-driven tools are being incorporated into clinical workflows faster than internal organizational oversight or compliance guidelines can keep up.
Medication intelligence is more than just drug data. It is a standardized, expertly curated, and maintained clinical knowledge layer that supports AI‑enabled decision support by providing structured, medication‑related information within auditable and explainable workflows.
AI readiness in healthcare: Building solutions with a trusted foundation
With so much at stake, healthcare organizations are increasingly evaluating digital health vendors based on their ability to demonstrate transparent, clinician-authored, and well-governed drug discovery intelligence and decision support capabilities.
There are three general characteristics of trustworthy drug data for clinical decision support for digital health vendors to consider when building AI solutions:
- Guardrails
- Clinical knowledge
- Workflow orchestration
To learn more about these key components of trustworthy medical intelligence and how digital health tech vendors are using them to build and scale successful AI-driven solutions, download the Fierce Healthcare and Wolters Kluwer whitepaper, “How medication intelligence scales trust in healthcare tech innovation.”
